An 18-yr-old male asthmatic was paralyzed with atracurium for a period
of seven days to facilitate mechanical pulmonary ventilation. After w
ithdrawal of the muscle relaxant, train-of-four neuromuscular monitori
ng demonstrated rapid recovery of normal function. Three days later he
developed acute quadriparesis without respiratory compromise. Electro
physiological studies showed normal conduction velocities, low compoun
d muscle action potential amplitudes and evidence of denervation. Most
cases of post-ventilatory weakness in the ICU involve the use of vecu
ronium and pancuronium. It has been suggested that the steroid nucleus
in these muscle relaxants may be responsible. Our patient developed g
eneralised weakness after treatment with atracurium, a benzylisoquinol
inium muscle relaxant. Thus, it appears that the steroid nucleus of ve
ntronium and pancuronium is not essential in causing post-ventilatory
weakness.